Literature DB >> 11836443

Methods of molecular analysis: assessing losses and gains in tumours.

R Roylance1.   

Abstract

The study of chromosomal aberrations has facilitated the understanding of tumorigenesis. By applying molecular genetic techniques to regions highlighted by cytogenetic study, many genes important in tumorigenesis have been identified. This review will describe the cytogenetic and molecular cytogenetic techniques used to identify these changes. The clinical information that they can provide, including diagnostic and prognostic information, will also briefly be discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11836443      PMCID: PMC1187142          DOI: 10.1136/mp.55.1.25

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  22 in total

1.  Karyotyping human chromosomes by combinatorial multi-fluor FISH.

Authors:  M R Speicher; S Gwyn Ballard; D C Ward
Journal:  Nat Genet       Date:  1996-04       Impact factor: 38.330

2.  Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining.

Authors:  J D Rowley
Journal:  Nature       Date:  1973-06-01       Impact factor: 49.962

Review 3.  Oncogene amplification in solid tumors.

Authors:  M Schwab
Journal:  Semin Cancer Biol       Date:  1999-08       Impact factor: 15.707

4.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

5.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

6.  Tissue culture loss of aneuploid cells from carcinomas of the prostate.

Authors:  J J König; W Teubel; J W van Dongen; A Hagemeijer; J C Romijn; F H Schröder
Journal:  Genes Chromosomes Cancer       Date:  1993-09       Impact factor: 5.006

Review 7.  Interrelationship between methodological choices and conceptual models in solid tumor cytogenetics.

Authors:  N Pandis; G Bardi; S Heim
Journal:  Cancer Genet Cytogenet       Date:  1994-09

Review 8.  Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors.

Authors:  O P Kallioniemi; A Kallioniemi; J Piper; J Isola; F M Waldman; J W Gray; D Pinkel
Journal:  Genes Chromosomes Cancer       Date:  1994-08       Impact factor: 5.006

9.  Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.

Authors:  T Visakorpi; A H Kallioniemi; A C Syvänen; E R Hyytinen; R Karhu; T Tammela; J J Isola; O P Kallioniemi
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

10.  Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma. United Kingdom Children's Cancer Study Group.

Authors:  C P Taylor; N P Bown; A G McGuckin; J Lunec; A J Malcolm; A D Pearson; D Sheer
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

View more
  4 in total

1.  Molecular pathology of solid tumours: translating research into clinical practice. Introduction and overview.

Authors:  I Tomlinson
Journal:  Mol Pathol       Date:  2001-08

Review 2.  Aneuploidy and malignancy: an unsolved equation.

Authors:  P Dey
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

3.  Application of a new probabilistic model for mining implicit associated cancer genes from OMIM and medline.

Authors:  Shanfeng Zhu; Yasushi Okuno; Gozoh Tsujimoto; Hiroshi Mamitsuka
Journal:  Cancer Inform       Date:  2007-02-25

Review 4.  Genetic alteration and gene expression modulation during cancer progression.

Authors:  Cathie Garnis; Timon P H Buys; Wan L Lam
Journal:  Mol Cancer       Date:  2004-03-22       Impact factor: 27.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.